logo

For the Inventor, By the Inventor

Shizuoka, Japan

Masahiro Sugimoto

This inventor holds 5 USPTO granted patents. Top assignee: Abbott Laboratories Corporation. Active years: 1977-1980.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masahiro Sugimoto. Retrieved from https://idiyas.com/inventor/masahiro-sugimoto-bzhkls6t

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 5

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 14(Granted Patents)


Location History:

  • Shizuoka, JA (1977 - 1978)
  • Shizuoka, JP (1979 - 1980)

Company Filing History:

goldMedal5 out of 4,190 
 
Abbott Laboratories Corporation
 patents

Years Active: 1977-1980

Loading Chart...
5 patents (USPTO):Explore Patents
1. 4216308 - Fortimicin factors D and KE compounds (1980-08-05),
2. 4209612 - Fortimicin factors KF and KG and process for production thereof (1980-06-24),
3. 4145253 - Process for producing fortimicin factors (1979-03-20),
4. 4097428 - Fortimicin C and process for production thereof (1978-06-27),
5. 4048015 - Fortimicin C and process for production thereof (1977-09-13),

Title: The Innovative Contributions of Masahiro Sugimoto

Introduction

Masahiro Sugimoto is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of antibiotic compounds, holding a total of 5 patents. His work focuses on the development of new antibiotic agents derived from microorganisms.

Latest Patents

Sugimoto's latest patents include the development of Fortimicin factors D and KE compounds. These new antibiotic compounds are produced through the fermentation of microorganisms belonging to the genus Micromonospora. The antibiotic compounds are accumulated in the culture liquor and are isolated therefrom. Additionally, he has disclosed a semisynthetic method of producing Fortimicin KE utilizing Fortimicin D. Another notable patent involves Fortimicin factors KF and KG, which are also produced by fermentation of Micromonospora. These compounds are similarly accumulated in the culture liquor and isolated for further use.

Career Highlights

Masahiro Sugimoto is currently associated with Abbott Laboratories Corporation, where he continues to innovate in the field of antibiotics. His work has been instrumental in advancing the development of new therapeutic agents that can combat bacterial infections.

Collaborations

Sugimoto collaborates with talented individuals such as Ryo Okachi and Takashi Nara, contributing to a dynamic research environment that fosters innovation.

Conclusion

Masahiro Sugimoto's contributions to antibiotic research exemplify the importance of innovation in healthcare. His patents reflect a commitment to developing effective treatments that can address pressing medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…